Visible-Light-Activated Molecular Nanomachines Kill Pancreatic Cancer Cells
Source abstract
Abstract
Recently, synthetic molecular nanomachines (MNMs) that rotate unidirectionally in response to UV light excitation have been used to produce nanomechanical action on live cells to kill them through the drilling of holes in their cell membranes. In the work here, visible-light-absorbing MNMs are designed and synthesized to enable nanomechanical activation by 405 nm light, thereby using a wavelength of light that is less phototoxic than the previously employed UV wavelengths. Visible-light-absorbing MNMs that kill pancreatic cancer cells upon response to light activation are demonstrated. Evidence is presented to support the conclusion that MNMs do not kill cancer cells by the photothermal effect when used at low optical density. In addition, MNMs suppress the formation of reactive oxygen species, leaving nanomechanical action as the most plausible working mechanism for cell killing under the experimental conditions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States
Department of Chemistry, Durham University, South Road, Durham DH1 3LE, U.K.
Funding
Biotechnology and Biological Sciences Research Council
References (27)
Show source-provided references
1. 10.1038/nature2365710.1038/nature23657 ↗
2. 10.1016/j.cell.2017.01.01710.1016/j.cell.2017.01.017 ↗
3. 10.18632/oncotarget.1840910.18632/oncotarget.18409 ↗
4. 10.1038/nrc395810.1038/nrc3958 ↗
5. 10.2741/307010.2741/3070 ↗
6. 10.1115/1.321282310.1115/1.3212823 ↗
7. 10.1038/nnano.2012.1910.1038/nnano.2012.19 ↗
8. 10.1039/C5SC04084A10.1039/C5SC04084A ↗
9. 10.1002/anie.20150638410.1002/anie.201506384 ↗
10. 10.1039/C5CS00874C10.1039/C5CS00874C ↗
11. 10.1021/acs.nanolett.5b0376410.1021/acs.nanolett.5b03764 ↗
12. 10.1039/b718294e10.1039/b718294e ↗
13. 10.1073/pnas.171278411510.1073/pnas.1712784115 ↗
14. 10.1002/adfm.20060102510.1002/adfm.200601025 ↗
15. 10.1021/acsnano.9b0155610.1021/acsnano.9b01556 ↗
16. Lee J. W. · 2016 · 73 · 14.39.1
17. 10.1016/j.cellbi.2006.06.01610.1016/j.cellbi.2006.06.016 ↗
18. 10.1155/1999/17651510.1155/1999/176515 ↗
19. Cummings B. S. · 2004 · 25 · 12.8.1
20. 10.1371/journal.pone.001020210.1371/journal.pone.0010202 ↗
21. 10.1186/s13104-015-1000-810.1186/s13104-015-1000-8 ↗
22. van Meerloo J. · 2011 · 23710.1007/978-1-61779-080-5_20 ↗
23. 10.1002/cyto.99013080210.1002/cyto.990130802 ↗
24. 10.1073/pnas.141770311210.1073/pnas.1417703112 ↗
25. 10.1016/j.biocel.2007.07.01410.1016/j.biocel.2007.07.014 ↗
26. 10.1042/BJ2013028210.1042/BJ20130282 ↗
27. 10.1016/S0040-4020(01)87036-810.1016/S0040-4020(01)87036-8 ↗